Aravive, Inc. (ARAV) financial statements (2022 and earlier)

Company profile

Business Address RIVER OAKS TOWER
HOUSTON, TX 77098
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments59,42460,54165,13456,99281,146201,153182,069
Cash and cash equivalents59,42460,54165,13456,99281,146201,153182,069
Receivables  2,504606   
Prepaid expense 8705314162613,4741,770
Other undisclosed current assets3,3212784416301678772
Total current assets:62,74561,68968,21358,03081,708205,305184,611
Noncurrent Assets
Operating lease, right-of-use asset2,2072,9588,697
Property, plant and equipment4005261,80832798265389
Intangible assets, net (including goodwill) 97219341   
Intangible assets, net (excluding goodwill) 97219341   
Restricted cash and investments2,431      
Other noncurrent assets41076120  327
Other undisclosed noncurrent assets 2,4302,42311,04711,271  
Total noncurrent assets:5,0426,02113,90811,44012,069265716
TOTAL ASSETS:67,78767,71082,12169,47093,777205,570185,327
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12,4704,8232,5751,7915,59314,5038,827
Accounts payable2,6572,5001,0784261,5001,3571,671
Accrued liabilities8,4162,3231,4971,3654,09312,8997,156
Employee-related liabilities1,397      
Taxes payable     247 
Deferred revenue4,5712,552 
Debt  2,393    
Deferred revenue and credits 40,000 
Other undisclosed current liabilities9002,086 146   
Total current liabilities:17,9419,4614,9681,9375,59354,5038,827
Noncurrent Liabilities
Long-term debt and lease obligation4,0766,4317,840    
Operating lease, liability4,0766,4317,840
Liabilities, other than long-term debt3,5483,763     
Deferred revenue3,5483,763 
Other undisclosed noncurrent liabilities  2647,5885,428  
Total noncurrent liabilities:7,62410,1948,1047,5885,428  
Total liabilities:25,56519,65513,0729,52511,02154,5038,827
Stockholders' equity
Stockholders' equity attributable to parent42,22248,05569,04959,94582,756151,067176,500
Common stock2221433
Additional paid in capital582,025548,707539,158510,509456,984440,667369,933
Accumulated other comprehensive loss     (350) 
Accumulated deficit(539,805)(500,654)(470,111)(450,565)(374,232)(289,253)(193,436)
Total stockholders' equity:42,22248,05569,04959,94582,756151,067176,500
TOTAL LIABILITIES AND EQUITY:67,78767,71082,12169,47093,777205,570185,327

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues7,4425,6854,7531,37140,000  
Revenue, net40,000  
Gross profit:7,4425,6854,7531,37140,000  
Operating expenses(48,091)(36,469)(26,527)(76,783)(124,482)(96,320)(82,508)
Operating loss:(40,649)(30,784)(21,774)(75,412)(84,482)(96,320)(82,508)
Nonoperating income (expense)1,4982413,5561,508(744)750331
Investment income, nonoperating372551,022989847514218
Other nonoperating income (expense)1,461(14)2,534519(1,591)236113
Interest and debt expense   (2,429)   
Loss from continuing operations before income taxes:(39,151)(30,543)(18,218)(76,333)(85,226)(95,570)(82,177)
Income tax expense (benefit)    247(247) 
Net loss available to common stockholders, diluted:(39,151)(30,543)(18,218)(76,333)(84,979)(95,817)(82,177)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(39,151)(30,543)(18,218)(76,333)(84,979)(95,817)(82,177)
Comprehensive loss:(39,151)(30,543)(18,218)(76,333)(84,979)(95,817)(82,177)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent    350(350) 
Comprehensive loss, net of tax, attributable to parent:(39,151)(30,543)(18,218)(76,333)(84,629)(96,167)(82,177)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: